Navigation Links
Kensey Nash Reports Second Quarter Fiscal Year 2011 Financial Results
Date:2/1/2011

EXTON, Pa., Feb. 1, 2011 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY), a medical device company primarily focused on regenerative medicine for a wide range of medical procedures, today reported the results for its second quarter ended December 31, 2010.  

Second Quarter Snapshot and Recent Developments

  • Diluted EPS of $0.38, in line with the Company's previous guidance of $0.37-$0.40, and representing an increase from the prior year comparable quarter's diluted EPS of $0.32 and a decrease from the prior year comparable quarter's adjusted diluted EPS*of $0.43.
  • Revenue of $17.4 million, in line with the Company's previous guidance of $17.0-$17.8 million and representing a decrease from the prior year comparable quarter's revenue of $19.1 million.
  • Net sales of $10.9 million, in line with the Company's previous guidance of $10.3-$11.0 million and representing a decrease from the prior year comparable quarter's net sales of $12.5 million.
  • Royalty income of $6.5 million, below the Company's previous guidance of $6.7-$6.8 million and representing a decrease from the prior year comparable quarter's royalty income of $6.6 million.
  • Operating margin of 29%.
  • Cash from operations of $2.2 million in the quarter.
  • EBITDA* of $6.8 million.
  • Entered into a manufacturing agreement with, and made a minority equity investment in, Orteq Sports Medicine, a medical device company specializing in the field of biodegradable polymer technology for meniscus repair.
  • Signed distribution agreement with Arthrex, Inc. for the European distribution of the Company's Cartilage Repair Device.
  • Acquired the net assets of Nerites Corporation, a developer of medical adhesives and anti-fouling coatings (See the Company's January 31, 2011 press release).

  • President and CEO Commentary "Although our secon
    '/>"/>

    SOURCE Kensey Nash Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related biology technology :

    1. Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
    2. Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results
    3. Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product
    4. Synthes and Kensey Nash Announce Strategic Agreement for Extracellular Matrix Products
    5. Kensey Nash to Present at the 2009 UBS Global Life Sciences Conference
    6. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
    7. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
    8. Par Pharmaceutical Reports Second Quarter 2008 Results
    9. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
    10. Pharmos Corporation Reports 2008 Second Quarter Results
    11. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/26/2014)... SoundConnect , an award winning unified communications ... Darren Suders has joined the team as Director of ... partner program through innovative offerings, consistent partner ... brings more than 10-years of channel telecommunication experience to ... from policy development, to partner education and to expansion. ...
    (Date:11/26/2014)... (PRWEB) November 26, 2014 2014 ... is an in-depth research report on the Global ... report introduces Palmitic Acid, basic information, including definition, ... analysis, and news analysis, etc. , For ... Palmitic Acid market in China and ...
    (Date:11/26/2014)... Bio-Techne Corporation (NASDAQ: TECH ) ... to serve in a newly created position of ... Gavin will be responsible for managing the operations of ... business acquired in July 2014 and the recently acquired ... -based ProteinSimple develops and commercializes proprietary systems and ...
    (Date:11/26/2014)... 2014  Roka Bioscience, Inc. (NASDAQ: ROKA ), ... for the detection of foodborne pathogens, today announced that ... 26 th Annual Healthcare Conference on December 2, 2014 ... New York Palace in New York, NY ... the Company, its operations, strategies and prospects may be discussed. ...
    Breaking Biology Technology:SoundConnect Appoints Director of Channel Development & Sales 2Palmitic Acid Industry Global 2014 Analysis & 2020 Forecasts on Market data, Statics, Development Now at ReportsnReports.com 2Palmitic Acid Industry Global 2014 Analysis & 2020 Forecasts on Market data, Statics, Development Now at ReportsnReports.com 3Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 2Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 3Roka Bioscience to Present at the Piper Jaffray Healthcare Conference 2
    ... time of year parents in northern regions bundle up ... to layers of warm clothing, gloves, and boots, parents ... the potential hazards of winter sports and play. Currently ... from the stresses and forces that may be encountered ...
    ... The Kansas Bioscience Authority (KBA) today released the just-completed forensic ... of Gov. Sam Brownback in April 2011 and conducted by ... are available at www.kansasbioauthority.org . KBA ... that the KBA,s investment process is diligent and it makes ...
    ... Aethlon Medical, Inc. (OTCBB: AEMD), ... to address infectious disease, cancer and other life-threatening ... Extracorporeal Therapy Scientific Advisory Board to guide the ... developed from the Aethlon ADAPT™ system.  Aethlon recently ...
    Cached Biology Technology:How well does protective headgear work for small children engaged in Winter activities? 2Auditors Complete Kansas Bioscience Authority Forensic Audits 2Auditors Complete Kansas Bioscience Authority Forensic Audits 3Auditors Complete Kansas Bioscience Authority Forensic Audits 4Aethlon Medical Establishes Extracorporeal Therapy Scientific Advisory Board 2Aethlon Medical Establishes Extracorporeal Therapy Scientific Advisory Board 3Aethlon Medical Establishes Extracorporeal Therapy Scientific Advisory Board 4Aethlon Medical Establishes Extracorporeal Therapy Scientific Advisory Board 5Aethlon Medical Establishes Extracorporeal Therapy Scientific Advisory Board 6Aethlon Medical Establishes Extracorporeal Therapy Scientific Advisory Board 7
    (Date:11/4/2014)... 4, 2014   Neurotechnology , a provider ... the latest version of its fingerprint matching algorithm ... MINEX evaluation organized by NIST. The MINEX ... the INCITS 378 fingerprint standard template format. MINEX ... tenders in the United States ...
    (Date:11/3/2014)...  NeuroSigma ® , Inc. (NeuroSigma), a ... on commercialization of its non-invasive Monarch ... neurological and neuropsychiatric disorders, announced today that the ... Notice of Allowance for Mexican Patent Application No. ... and the Regents of the University of California ...
    (Date:11/2/2014)... NEW ORLEANS, LA (2 November 2014)—In support of a ... the Bill & Melinda Gates Foundation today announced an ... PATH Malaria Vaccine Initiative (MVI) in building new vaccines ... and help realize the "accelerating to zero" agenda. Such ... providing what could be called an "immunological bed net." ...
    Breaking Biology News(10 mins):Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 3NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3New malaria vaccines to prevent infection and block transmission get a shot in the arm 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 3New malaria vaccines to prevent infection and block transmission get a shot in the arm 4
    ... model used to predict which websites people are most apt ... lung cancer spreads in the human body, according to a ... A team of researchers used an algorithm similar to ... communication to analyze the spread patterns of lung cancer. The ...
    ... millions of tons of environmentally harmful ash is produced worldwide, ... countries, used as construction material. The ash is what is ... A researcher from Lund University in Sweden has now developed ... The method is presented in a new thesis. ...
    ... is challenging because fluctuating wind speed and direction means ... demand, many wind-farm managers end up wasting power-generation capacity ... control including fully stopping turbines in ... grid from spikes in supply. In a paper published ...
    Cached Biology News:New lung cancer study takes page from Google's playbook 2Ash from refuse could become hydrogen gas 2
    ... Disruption of the mitochondrial transmembrane ... intracellular events that occur following induction ... Detection Kit utilizes a lipophilic cation, ... activity marker. MitoLight is a mitochondrial ...
    ... ProteinChip arrays have been developed for ... samples. A variety of ProteinChip chemical ... according to their unique biochemical properties. ... allowing side-by-side sample comparison, and the ...
    ... VersArray ChipWriter Pro systems are ... proteins, or other biological samples. VersArray ... for uniformity, spot density, and reproducibility ... a variety of substrates. Their modular ...
    ... Ciphergen's ProteinChip arrays have been developed ... biological samples. A variety of ProteinChip ... proteins according to their unique biochemical ... spots, allowing side-by-side sample comparison, and ...
    Biology Products: